1) IBS-C
便秘型肠易激综合征
1.
Objective To evaluate the clinical efficacy on constipation-dominant irrtable bowel syndrome(IBS-C) treated on-demand with tegaserod combined with medilac-s in improving patients stool description,clinical symptom and quality of life.
目的探讨替加色罗联合微生态制剂按需给药治疗便秘型肠易激综合征(constipation-dominant irritable bowel syndrome,IBS-C)的临床疗效和可行性。
2.
Objective To evaluate the clinical efficacy on constipation-dominant irrtable bowel syndrome(IBS-C)treated with Zhishu decoction.
目的探讨《金匮》枳术汤加减治疗便秘型肠易激综合征(constipation-dominant irritable bowel syndrome,IBS-C)的临床疗效。
3.
Objective: To study the clinical effect on C-irrtable bowel syndrome (IBS-C) treated on-demand with tegaserod combined with medilac-s in improving patients stool description, clinical symptom and quality of life.
目的在应用替加色罗(商品名:泽马可)联合微生态制剂(商品名:美常安)治疗便秘型肠易激综合征过程中,通过对按需给药与系统给药两种治疗方式在改善患者大便性状、临床症状及生活质量方面的治疗效果进行比较,评价按需给药方式的有效性,从而探讨按需给药治疗的可行性,为临床治疗方案的制定提供一定参考。
2) constipation-predominant irritable bowel syndrome
便秘型肠易激综合征
1.
Objective:The purpose of this study addition SINISAN United trimebutine maleate treatment of constipation-predominant irritable bowel syndrome than trimebutine maleate treatment of constipationpredominant irritable bowel syndrome have advantages.
目的:本研究旨在探讨四逆散加味联合马来酸曲美布汀治疗便秘型肠易激综合征较马来酸曲美布汀治疗便秘型肠易激综合征疗效是否具有优越性。
2.
Methods: constipation-predominant irritable bowel syndrome (ganwei not permit) a total of 60 patients were randomly divided into treatment group 30 cases, 30 cases of the control group, treatment group oral Yueju Tang, Morning and evening, each 100ml serving temperature.
方法:选择便秘型肠易激综合征(肝胃不和证)患者共60例,随机分为治疗组30例,对照组30例,治疗组口服越鞠汤加减,早晚各100ml温服。
3) constipation irritable bowel syndrome
便秘型肠易激综合征
1.
Control study of Wuling capsule on constipation irritable bowel syndrome accompanied with depression;
乌灵胶囊治疗伴有抑郁症状的便秘型肠易激综合征的对照研究
2.
[Methods]To select patients of excerpt diarrhea irritable bowel syndrome and constipation irritable bowel syndrome and divide them into two group:one is called treatment group and other is called comparison group.
[方法]选择腹泻型肠易激综合征与便秘型肠易激综合征患者分别分成治疗组和对照组,治疗后进行疗效观察,各型组间进行统计学分析。
4) Irritable bowel syndrome with constipation
肠易激综合征便秘型
5) Constipation-predominant IBS
便秘型-肠易激综合征
6) non constipated irritable bowel syndrome
非便秘型肠易激综合症
1.
Objective To explore the treatment using nifedipine combined with oryzanol against non constipated irritable bowel syndrome.
目的探讨硝苯吡啶联用谷维素治疗非便秘型肠易激综合症。
补充资料:易肠鼠
1.传说中的鼠名。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条